Sale!

CYP7B1 Gene SPG5A Genetic Test

Original price was: $700.Current price is: $500.

-29%

The CYP7B1 Gene SPG5A NGS Genetic DNA Test is a comprehensive diagnostic tool that identifies mutations in the CYP7B1 gene responsible for hereditary spastic paraplegia type 5A (SPG5A). This advanced next-generation sequencing test provides crucial information for patients experiencing progressive leg stiffness, walking difficulties, and neurological symptoms. The test helps confirm diagnosis, guide treatment strategies, and provide essential genetic counseling for family planning. Results are available within 3-4 weeks using blood, extracted DNA, or FTA card samples. The test is priced at $500 USD (regularly $700 USD) and includes pre-test genetic counseling to create detailed family pedigree charts.

Trusted Testing. Expert Care. Guaranteed Privacy.

  • Accredited and Trusted
  • Expert Scientists, Advanced Technology
  • Data Privacy Guaranteed
Guaranteed Safe Checkout

CYP7B1 Gene SPG5A NGS Genetic DNA Test

Understanding Hereditary Spastic Paraplegia Type 5A

The CYP7B1 Gene SPG5A NGS Genetic DNA Test represents a breakthrough in neurological genetic diagnostics, specifically designed to identify mutations in the CYP7B1 gene that cause hereditary spastic paraplegia type 5A (SPG5A). This autosomal recessive condition affects the nervous system, leading to progressive stiffness and weakness in the lower limbs. Our advanced testing methodology provides patients and healthcare providers with definitive diagnostic information crucial for managing this complex neurological disorder.

What Does the Test Detect?

This comprehensive genetic analysis utilizes next-generation sequencing (NGS) technology to examine the entire CYP7B1 gene for pathogenic variants. The test specifically identifies:

  • Point mutations and small insertions/deletions in the CYP7B1 gene
  • Autosomal recessive inheritance patterns
  • Mutations affecting oxysterol 7-alpha-hydroxylase enzyme function
  • Genetic variants associated with progressive spastic paraplegia
  • Carrier status for family members

Who Should Consider This Test?

This genetic test is recommended for individuals presenting with symptoms suggestive of hereditary spastic paraplegia, including:

  • Progressive leg stiffness and weakness beginning in childhood or early adulthood
  • Difficulty walking with spastic gait
  • Muscle spasms and hyperreflexia in lower extremities
  • Family history of similar neurological symptoms
  • Unexplained progressive neurological deterioration
  • Patients with suspected autosomal recessive inheritance patterns

Clinical Indications Include:

  • Differential diagnosis of spastic paraplegias
  • Confirmation of SPG5A diagnosis
  • Genetic counseling for family planning
  • Carrier testing for at-risk relatives
  • Prenatal diagnosis considerations

Benefits of CYP7B1 Genetic Testing

Undergoing this comprehensive genetic analysis provides numerous advantages for patients and families:

  • Definitive Diagnosis: Confirms or rules out SPG5A with high accuracy
  • Treatment Guidance: Informs targeted management strategies
  • Family Planning: Provides essential information for reproductive decisions
  • Prognostic Information: Helps understand disease progression patterns
  • Genetic Counseling: Supports informed decision-making for entire families
  • Research Contribution: Advances understanding of rare neurological disorders

Understanding Your Test Results

Our comprehensive genetic counseling services help you interpret your results effectively:

  • Positive Result: Indicates pathogenic mutations in both CYP7B1 gene copies, confirming SPG5A diagnosis
  • Carrier Status: Identifies individuals with one mutated gene copy who may pass the condition to offspring
  • Negative Result: Suggests alternative diagnoses should be considered for symptomatic individuals
  • Variant of Uncertain Significance: Requires additional family studies and clinical correlation

Test Specifications

Test Parameter Details
Test Name CYP7B1 Gene SPG5A NGS Genetic DNA Test
Discount Price $500 USD
Regular Price $700 USD
Turnaround Time 3 to 4 Weeks
Sample Type Blood, Extracted DNA, or One Drop Blood on FTA Card
Testing Method Next-Generation Sequencing (NGS)
Specialty Neurology & Genetics

Pre-Test Requirements

Before testing, we provide comprehensive genetic counseling services including:

  • Detailed clinical history assessment
  • Family pedigree chart development
  • Explanation of testing process and implications
  • Informed consent discussion
  • Insurance and payment options review

Nationwide Testing Availability

We proudly serve patients across the United States with convenient testing locations in all major metropolitan areas including New York, Los Angeles, Chicago, Houston, Phoenix, Philadelphia, San Antonio, San Diego, Dallas, San Jose, and many more. Our network of certified genetic counselors and neurological specialists ensures you receive comprehensive care regardless of your location.

Take Control of Your Neurological Health

Don’t let uncertainty about hereditary spastic paraplegia affect your quality of life. Our CYP7B1 Gene SPG5A NGS Genetic DNA Test provides the clarity you need for informed medical decisions and family planning. With our discounted price of $500 USD and comprehensive genetic counseling services, you can access world-class neurological genetic testing without financial burden.

Ready to begin your diagnostic journey? Contact our genetic specialists today at +1(267) 388-9828 or book your appointment online. Take the first step toward understanding your genetic health and securing your family’s future.